Retail clinicians are well situated to offer tips to reduce acid reflux symptoms during the holidays.
Retail clinicians are well situated to offer tips to reduce acid reflux symptoms during the holidays.
Acid reflux affects an estimated 45% of the US population, but with theholiday seasonin full swing, heartburn related to eating and drinking is likely to impact an even greater population.
When episodes regularly occur over a 2-week period, the patient is probably experiencinggastroesophageal reflux disease(GERD).
Beyond recommendingOTC options, retail clinicians can advise the following lifestyle changes to patients seeking to reduce their GERD symptoms:
1. Stop Smoking
There are many reasons why smoking is not a great habit for health, and the exacerbation of GERD symptoms is one of them.
Smoking relaxes the lower esophageal sphincter and increases acid reflux.
Even worse than smoking cigarettes may be chewing tobacco, which involves a constant release of the stimulant.
2. Avoid Trigger Drinks
Beverages that can bring on orexacerbate heartburnsymptoms include:
3. Avoid Trigger Foods
Diet adjustment is a key strategy in reducing the frequency and severity of heartburn symptoms.
Foods associated with increased symptoms of heartburn include:
4. Lose Weight
Excess abdominal weight places pressure on the stomach, which causes its contents to reflux more easily. Wearing clothing that is too tight can also cause this issue.
Losing weight, however, can reduce this effect and bring relief. Eating more slowly may also help to relieve heartburn symptoms.
Eating smaller meals with smaller portions sizes more often can help reduce heartburn effects that coincide with being full.
5. Lay Flat
Patients should raise the top of their mattress about 6 to 8 inches if they can. Lying flat reduces gravity, thereby allowing the contents of the stomach to flux more easily.
If that’s not an option, patients can be advised to not eat within 3 hours of lying down at bedtime.
FDA Approves Rezafungin Injection for the Treatment of Candidemia, Invasive Candidiasis
March 27th 2023Rezafungin (Rezzayo; Cidara Therapeutics Inc, Melinta Therapeutics LLC) is the first new treatment option approved for individuals with candidemia and invasive candidiasis in more than a decade.